CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Prednisone 1 week +1 moredrug
Likely dose
Prednisone 1 week 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01837433
NCT01837433Phase 4Completed
CompareCT.gov

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis

Xinqiao Hospital of Chongqing·interventional·Posted Apr 23, 2013·Updated May 20, 2015

In Brief

A Phase 4 clinical trial evaluating Prednisone 1 week and Prednisone 6 weeks for Subacute Thyroiditis. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Efficiency and Safety Study of Short-term Prednisone to Treat Moderate and Severe Subacute Thyroiditis The investigators hypothesize that less adverse reactions will be observed, comparing with the guidelines recommend. The recurrence rate, adrenal insufficiency, temporary and permanent hypothyroidism aren't significant difference.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSubacute Thyroiditis
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 23, 2013
Enrollment StartMar 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.2 years ago

Interventions

Prednisone 1 weekdrug

Prednisone 1 week 30mg/day and Celecoxib 400mg in first day, and then 200mg bid in the remaining next week, total 2 weeks.

Prednisone 6 weeksdrug

Guidelines recommend